Ueno; Tatsuhiko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ueno; Tatsuhiko.The latest application filed is for "bicyclic heterocycle derivatives having selective bace1 inhibitory activity".

Company Profile

1.7.13

Ueno; Tatsuhiko - Toyonaka JP
UENO; Tatsuhiko - Osaka JP
UENO; Tatsuhiko - Toyonaka-shi Osaka
Ueno; Tatsuhiko - Toyanaka JP
UENO; Tatsuhiko - Osaka-shi JP
Ueno; Tatsuhiko - Osaka-fu JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Stereoselective process for preparing substituted polycyclic pyridone derivatives Grant 11,286,262 - Okamoto , et al. March 29, 2	2022-03-29
Bicyclic Heterocycle Derivatives Having Selective Bace1 Inhibitory Activity App 20210261561 - UENO; Tatsuhiko ; et al.	2021-08-26
Stereoselective Process For Preparing Substituted Polycyclic Pyridone Derivatives App 20200247818 - Kind Code	2020-08-06
Method For Producing Triphenylbutene Derivative App 20170297999 - Okamoto; Kazuya ; et al.	2017-10-19
Aromatic heterocyclylamine derivative having TRPV4-inhibiting activity Grant 9,708,338 - Yukimasa , et al. July 18, 2	2017-07-18
Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity Grant 9,650,371 - Hori , et al. May 16, 2	2017-05-16
Sulfur-containing Heterocyclic Derivative Having Beta Secretase Inhibitory Activity App 20160326158 - HORI; Akihiro ; et al.	2016-11-10
Aromatic Heterocyclylamine Derivative Having Trpv4-inhibiting Activity App 20160200721 - YUKIMASA; Akira ; et al.	2016-07-14
Sulfur-containing Heterocyclic Derivative Having Beta Secretase Inhibitory Activity App 20160108052 - Hori; Akihiro ; et al.	2016-04-21
Oxime-substituted Quinoxaline-type Piperidine Compounds As Orl-1 Modulators App 20150238485 - MARRA; Jeffrey Michael ; et al.	2015-08-27
Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators Grant 9,085,561 - Tsuno , et al. July 21, 2	2015-07-21
Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators Grant 9,040,533 - Marra , et al. May 26, 2	2015-05-26
Aminodihydrothiazine derivatives substituted with a cyclic group Grant 8,884,062 - Tamura , et al. November 11, 2	2014-11-11
Oxime-substituted-quinoxaline-type Piperidine Compounds And Uses Thereof App 20140187544 - MARRA; Jeffrey Michael ; et al.	2014-07-03
Aminodihydrothiazine Derivatives Substituted With A Cyclic Group App 20140073815 - TAMURA; Yuusuki ; et al.	2014-03-13
Cyclic Urea- Or Lactam-substituted Quinoxaline-type Piperidine Compounds And Uses Thereof App 20140045830 - TSUNO; Naoki ; et al.	2014-02-13
Aminodihydrothiazine Derivatives Substituted With A Cyclic Group App 20120172355 - TAMURA; Yuusuke ; et al.	2012-07-05
Aminodihydrothiazine derivatives substituted with a cyclic group Grant 8,168,630 - Tamura , et al. May 1, 2	2012-05-01
Sulfur-containing Heterocyclic Derivative Having Beta Secretase Inhibitory Activity App 20110190279 - Hori; Akihiro ; et al.	2011-08-04
Aminodihydrothiazine Derivatives Substituted With A Cyclic Group App 20100075957 - Tamura; Yuusuke ; et al.	2010-03-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.